Comparison of RAD51 expression in eight cell lines derived from mammary tumors using western blotting in G0 and S phases synchronized using double thymidine block revealed that the expression levels varied among cell lines, but no differences were observed between cell cycles. Here, RAD51 is linked to breast cancer.